Biodesix, Inc.
BDSX
$24.00
$0.210.88%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 102.94M | 96.10M | 88.50M | 80.17M | 76.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 102.94M | 96.10M | 88.50M | 80.17M | 76.56M |
| Cost of Revenue | 18.41M | 17.62M | 16.72M | 16.18M | 16.26M |
| Gross Profit | 84.53M | 78.48M | 71.78M | 63.99M | 60.30M |
| SG&A Expenses | 93.23M | 91.36M | 87.55M | 84.79M | 83.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 123.92M | 121.40M | 116.27M | 112.52M | 110.45M |
| Operating Income | -20.98M | -25.30M | -27.77M | -32.35M | -33.89M |
| Income Before Tax | -27.76M | -31.96M | -35.27M | -39.54M | -41.08M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.76 | -31.96 | -35.27 | -39.54 | -41.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.76M | -31.96M | -35.27M | -39.54M | -41.08M |
| EBIT | -20.98M | -25.30M | -27.77M | -32.35M | -33.89M |
| EBITDA | -15.41M | -19.67M | -22.10M | -26.61M | -28.08M |
| EPS Basic | -3.17 | -4.03 | -4.74 | -5.37 | -5.61 |
| Normalized Basic EPS | -2.01 | -2.54 | -2.95 | -3.34 | -3.49 |
| EPS Diluted | -3.17 | -4.03 | -4.74 | -5.37 | -5.61 |
| Normalized Diluted EPS | -2.01 | -2.54 | -2.95 | -3.34 | -3.49 |
| Average Basic Shares Outstanding | 35.52M | 32.55M | 30.20M | 29.46M | 29.28M |
| Average Diluted Shares Outstanding | 35.52M | 32.55M | 30.20M | 29.46M | 29.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |